Healthy Patients
Antimicrobial resistance (AMR)
AMR develops when bacteria, fungi or viruses are exposed to antibiotics, antifungals or antivirals. As a result, the antimicrobials become ineffective and infections may persist. In addition, medical interventions including surgery, chemotherapy and stem cell therapy may become impossible.
AMR is considered the biggest global threat of Health and Food Safety.
AMR Insights
For Healthcare professionals who wish to prevent Antimicrobial resistance, AMR Insights offers selected, global information and data, specific education and extensive networking and partnering opportunities.
AMR Insights is for:
- Medical Microbiologists, Infectiologists and other specialists
- General Practitioners, Pharmacists
- Infection Prevention Experts and nurses
- Medical Docters and Caretakers in nursing homes
- Managers and Labtechnicians of Microbiological Laboratories.
Latest Topics
-
13 October 2025Effectiveness of a structured educational training program on antimicrobial resistance among community health workers in Karnataka, India
This study in India assessed the impact of a structured antimicrobial resistance (AMR) training program for Accredited Social Health Activists (ASHAs). A three-day educational intervention among 103 ASHAs from selected Primary Health Centres significantly improved their knowledge, attitudes, and practices (KAP) regarding antibiotic use and AMR. Misconceptions—such as using antibiotics for viral infections—dropped sharply (from […]
Read more... -
10 October 2025A One Health framework for global and local stewardship across the antimicrobial lifecycle
Antimicrobial resistance (AMR) is a complex One Health challenge that impacts humans, animals, plants, and the environment, threatening global health, food security, and economies. Addressing it requires coordinated stewardship across the entire antimicrobial lifecycle—from research and development to production, market authorization, selection and supply, appropriate use, and final disposal—as defined by WHO, FAO, and WOAH. […]
Read more... -
10 October 2025Overcoming Antimicrobial Resistance: Phage Therapy as a Promising Solution to Combat ESKAPE Pathogens
This review highlights the renewed promise of bacteriophage (phage) therapy as an alternative to antibiotics in combating multidrug-resistant (MDR) ESKAPE pathogens—major drivers of hospital-acquired infections. It outlines phages’ unique antibacterial mechanisms, including targeted bacterial lysis, enzymatic biofilm disruption, and synergistic effects with antibiotics. The paper emphasizes the importance of advanced delivery systems (liposomes, hydrogels, nanofibers, […]
Read more...
More news related to Healthy patients
